Health & Environmental Research Online (HERO)


Print Feedback Export to File
7015977 
Journal Article 
Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells 
Li, F; Yang, Y; Zhu, P; Chen, W; Qi, D; Shi, X; Zhang, C; Yang, Z; Li, P; , 
2012 
Yes 
Fitoterapia
ISSN: 0367-326X 
ELSEVIER 
AMSTERDAM 
83 
8 
1443-1450 
English 
22951288 
WOS:000312916400021 
Echinacoside (ECH), isolated from Cistanche tubulosa (Schrenk) R. Wight stems, was subjected to in vitro experiments to investigate its bioactivities on proliferation, differentiation and mineralization of the osteoblastic cell line MC3T3-E1. MTT assay, the alkaline phosphatase (ALP) activity and calcium deposition were determined, and the secretion of collagen I (COL I), osteocalcin (OCN), osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) were also assayed by enzyme-linked immunosorbent assay (ELISA). The results showed that ECH caused a significant increase in cell proliferation, ALP activity, COL I contents, OCN levels and an enhancement of mineralization in osteoblasts at the concentration range from 0.01 to 10nmol·L(-1) (p<0.05), suggesting that ECH has a stimulatory effect on osteoblastic bone formation or has potential activity against osteoporosis. In addition, the ratio of OPG/RANKL also could be enhanced by ECH. These findings provide the potent evidence that ECH can promote bone regeneration in cultured osteoblastic MC3T3-E1 cells, which might be done by elevating the OPG/RANKL ratio, and potential evidence for echinacoside to be a promising drug or a lead compound in the development of disease-modifying drug to prevent osteoporosis.